At DeLand Treatment Solutions, we offer programs and treatment solutions that go beyond what is typically provided at other facilities. As our name suggests, we are not simply a treatment center, but ...
Imatinib (Imkeldi) is the first oral liquid TKI approved for multiple cancers, enhancing treatment accessibility and dosing precision. The drug is effective as a first-line treatment, especially in ...
Substance use disorder (SUD) remains a costly and dangerous public health challenge that affects over 48 million people in the US annually. High relapse rates, typically 40-60%, lead me to believe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results